Senseonics Holdings, Inc. (NYSE: SENS) rose 37.1% to $2.81 in pre-market trading after the company disclosed results from a PROMISE study evaluating its Eversense CGM System for up to 180 days. The Eversense CGM is a continuous glucose monitoring device. Q&K International Group Limited (NASDAQ: QK) rose 25.3% to $1.88 in pre-market trading after surging 23% on Thursday. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose 22.9% to $1.72 in pre-market trading after gaining over 5% on Thursday. Purple Biotech Ltd. (NASDAQ: PPBT) rose 15.5% to $7.76 in pre-market trading after gaining over 8% on Thursday. Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 15% to $14.99 in pre-market trading. Coherus and Junshi Bio disclosed that toripalimab in combo with chemo met primary endpoint as the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma. Asana, Inc. (NYSE: ASAN) rose 11.4% to $41.00 in pre-market trading after the company reported better-than-expected Q1 results and issued strong sales guidance . Progenity, Inc. (NASDAQ: PROG) shares rose 11.4% to $2.35 in pre-market trading. The company reported NB Alternatives GP Holdings bought 1,268,115 shares at an average price of $2.86. Leap Therapeutics, Inc. (NASDAQ: LPTX) rose 10.6% to $1.78 in pre-market trading. Hearing Baird initiated coverage with Outperform rating and a $5 price target. Synthetic Biologics, Inc. (NYSE: SYN) rose 10.4% to $0.6350 in pre-market trading. Synthetic Biologics recently regained compliance with NYSE American continued listing standards. Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) rose 10.2% to $1.30 in pre-market trading. Idera Pharma’s Form 4 filing from the company Director, Michael Dougherty, showed the purchase of 85,000 shares of common stock. Kandi Technologies Group, Inc. (NASDAQ: KNDI) rose 10.1% to $6.19 in pre-market trading as traders circulated Zacks article titled ‘KNDI: New Product Initiatives Portend Well For Accelerating Momentum.’ SuperCom Ltd. (NASDAQ: SPCB) rose 7.7% to $1.40 in pre-market trading. SuperCom recently reported Q1 results. Viant Technology Inc. (NASDAQ: DSP) shares rose 6.8% to $35.05 in pre-market trading. Viant Technology, last month, reported better-than-expected Q1 results. Envestnet, Inc. (NYSE: ENV) rose 6.5% to $76.20 in pre-market trading. Envestnet will replace TCF Financial Corp in the S&P MidCap 400 effective Wednesday, June 9. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 6.1% to $9.67 in pre-market trading. Clean Energy Fuels shares gained 12% on Thursday amid rumors Craig-Hallum mentioned natural gas as a low-risk decarbonization path for fleets and mentioned the company as a ‘partner of choice.’ Five Below Inc (NASDAQ: FIVE) rose 5.7% to $188.00 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 guidance. DocuSign, Inc. (NASDAQ: DOCU) rose 5.3% to $205.00 in pre-market trading after the company reported better-than-expected Q1 results and issued strong sales guidance. MongoDB, Inc. (NASDAQ: MDB) rose 3.3% to $280.00 in pre-market trading after the company reported better-than-expected Q1 results and issued upbeat FY22 guidance.
Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.
NGL Energy Partners LP (NYSE: NGL) fell 13.7% to $2.70 in pre-market trading after the company reported weaker-than-expected Q4 results. AMC Entertainment Holdings, Inc. (NYSE: AMC) fell 6.8% to $47.86 in pre-market trading after tumbling 18% on Thursday. Arbutus Biopharma Corporation (NASDAQ: ABUS) shares fell 6.8% to $2.75 in pre-market trading. BriaCell Therapeutics Corp. (NASDAQ: BCTX) fell 5.8% to $5.70 in pre-market trading. BriaCell Therapeutics recently reported private placement of 5.17 million units at $5.26 per unit. Pagerduty Inc (NYSE: PD) shares fell 4.1% to $38.99 in pre-market trading after the company issued weak Q2 EPS guidance. Sumo Logic Inc (NASDAQ: SUMO) fell 3.6% to $17.99 in pre-market trading after the company issued weak EPS guidance.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.